Search research articles
Contact Us
Filters
Showing results (91-100 of 121) with videos related to
Page
of 13
Sort By:
The Lancet. Rheumatology
|
June 6, 2020
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro, et al.
Annals of the Rheumatic Diseases
|
February 25, 2025
A coding single nucleotide polymorphism in the interleukin-6 receptor enhances IL-6 signalling in CD4 T cells and predicts treatment response to tocilizumab in giant cell arteritis
Robert Zorc, Christopher Redmond, McKella Sylvester, et al.
Seminars in Arthritis and Rheumatism
|
May 10, 2022
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data
Andrea K Hemmig, Daniele Gozzoli, Laura Werlen, et al.
Rheumatology (Oxford, England)
|
March 26, 2025
Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre study
Adrien Cottu, Laure Delaval, Alexandra Forestier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 6, 2025
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases
Maria Giulia Caponcello, Paula Olivares Navarro, Cecilia Bonazzetti, et al.
Blood
|
October 23, 2023
Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and France
Francesco Peyronel, Julien Haroche, Corrado Campochiaro, et al.
Rheumatology (Oxford, England)
|
February 21, 2023
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production
Eleonora Cantoni, Ivan Merelli, Davide Stefanoni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study
Tali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.
Annals of the Rheumatic Diseases
|
May 15, 2023
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients
Sara Monti, Alessandra Milanesi, Catherine Klersy, et al.
Nature Medicine
|
April 8, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome
Raffaella Molteni, Martina Fiumara, Corrado Campochiaro, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 121) with videos related to
Sort By:
Page
of 13
The Lancet. Rheumatology
|
June 6, 2020
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro, et al.
Annals of the Rheumatic Diseases
|
February 25, 2025
A coding single nucleotide polymorphism in the interleukin-6 receptor enhances IL-6 signalling in CD4 T cells and predicts treatment response to tocilizumab in giant cell arteritis
Robert Zorc, Christopher Redmond, McKella Sylvester, et al.
Seminars in Arthritis and Rheumatism
|
May 10, 2022
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data
Andrea K Hemmig, Daniele Gozzoli, Laura Werlen, et al.
Rheumatology (Oxford, England)
|
March 26, 2025
Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre study
Adrien Cottu, Laure Delaval, Alexandra Forestier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 6, 2025
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases
Maria Giulia Caponcello, Paula Olivares Navarro, Cecilia Bonazzetti, et al.
Blood
|
October 23, 2023
Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and France
Francesco Peyronel, Julien Haroche, Corrado Campochiaro, et al.
Rheumatology (Oxford, England)
|
February 21, 2023
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production
Eleonora Cantoni, Ivan Merelli, Davide Stefanoni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study
Tali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.
Annals of the Rheumatic Diseases
|
May 15, 2023
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients
Sara Monti, Alessandra Milanesi, Catherine Klersy, et al.
Nature Medicine
|
April 8, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome
Raffaella Molteni, Martina Fiumara, Corrado Campochiaro, et al.
Page
of 13